Description
The estimated global connected drug delivery devices market size was at USD 272.10 Million in 2021, and it is expected to reach 4167.8 Million in 2028 with a CAGR of 35.6% during the forecast period of 2022-2028. Augmented patient attention and connectivity owing to the growing penetration of the Internet of Things (IoT) in the medical instruments sector is predicted to propel the market. The demand has encountered exponential enlargement due to the rising market for drug delivery solutions utilized at home. The product is expected to continue to notice massive evolution in the hereafter, owing to the rising focus on the present direction of improved patient observation and quality of supervision, growing awareness concerning production footprint and associated expenses, and increasing use of self-administered and connected drug treatment.
